U.S. FDA Warning Letters Highlight Increased Scrutiny For Foreign Drug Makers
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA issues five warning letters to foreign drug makers for failing to register their products as agency beefs up efforts to ensure international compliance.